Adjunctive Therapy

Among patients with acute ischemic stroke from large-vessel occlusion, endovascular thrombectomy alone was noninferior for 90-day functional outcomes to IV alteplase administered within 4.5 hours from symptom onset plus endovascular thrombectomy.

A potential target for improving residual lipid-related risk for atherosclerotic CVD is reduction in triglyceride levels. Studies have shown eicosapentaenoic acid is effective in lowering triglyceride levels and reducing the risk for ischemic events in patients with elevated triglyceride levels already taking statin therapy.